...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons.
【24h】

Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons.

机译:神经营养蛋白可差异性增强基底前脑神经元中的乙酰胆碱释放,乙酰胆碱含量和胆碱乙酰转移酶活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Several lines of evidence indicate that nerve growth factor is important for the development and maintenance of the basal forebrain cholinergic phenotype. In the present study, using rat primary embryonic basal forebrain cultures, we demonstrate the differential regulation of functional cholinergic markers by nerve growth factor treatment (24--96 h). Following a 96-h treatment, nerve growth factor (1--100 ng/mL) increased choline acetyltransferase activity (168--339% of control), acetylcholine content (141--185%), as well as constitutive (148--283%) and K(+)-stimulated (162--399%) acetylcholine release, but increased release was not accompanied by increased high-affinity choline uptake. Enhancement of ACh release was attenuated by vesamicol (1 microM), suggesting a vesicular source, and was abolished under choline-free conditions, emphasizing the importance of extracellular choline as the primary source for acetylcholine synthesized for release. A greater proportion of acetylcholine released from nerve growth factor-treated cultures than from nerve growth factor-naive cultures was blocked by voltage-gated Ca(2+) channel antagonists, suggesting that nerve growth factor modified this parameter of neurotransmitter release. Cotreatment of NGF (20 ng/mL) with K252a (200 nM) abolished increases in ChAT activity and prevented enhancement of K(+)-stimulated ACh release beyond the level associated with K252a, suggesting the involvement of TrkA receptor signaling. Also, neurotrophin-3, neurotrophin-4 and brain-derived neurotrophic factor (all at 5--200 ng/mL) increased acetylcholine release, although they were not as potent as nerve growth factor and higher concentrations were required. High brain-derived neurotrophic factor concentrations (100 and 200 ng/mL) did, however, increase release to a level similar to nerve growth factor. In summary, long-term exposure (days) of basal forebrain cholinergic neurons to nerve growth factor, and in a less-potent fashion the other neurotrophins, enhanced the release of acetylcholine, which was dependent upon a vesicular pool and the availability of extracellular choline.
机译:几条证据表明,神经生长因子对于基底前脑胆碱能表型的发展和维持很重要。在本研究中,使用大鼠原代胚胎基底前脑培养物,我们证明了神经生长因子治疗(24--96 h)对功能性胆碱能标志物的差异调节。经过96小时的治疗,神经生长因子(1--100 ng / mL)增加了胆碱乙酰转移酶的活性(对照组的168--339%),乙酰胆碱含量(141--185%)以及组成型(148- -283%)和K(+)刺激的(162--399%)乙酰胆碱释放,但释放增加并没有增加高亲和力胆碱摄取。 ACh释放的增强被维他命(1 microM)减弱,表明是囊泡来源,并且在无胆碱的条件下被取消,强调了细胞外胆碱作为合成用于释放的乙酰胆碱的主要来源的重要性。电压门控的Ca(2+)通道拮抗剂阻止了从神经生长因子处理过的培养物中释放的乙酰胆碱比例大于从神经生长因子未经处理的培养物中释放的乙酰胆碱,表明神经生长因子修饰了该参数的神经递质释放。 NGF(20 ng / mL)与K252a(200 nM)的共处理消除了ChAT活性的增加,并阻止了K(+)刺激的ACh释放的增强,超过了与K252a相关的水平,表明TrkA受体信号的参与。同样,神经营养蛋白3,神经营养蛋白4和脑源性神经营养因子(均为5--200 ng / mL)增加了乙酰胆碱的释放,尽管它​​们不如神经生长因子那么有效,并且需要更高的浓度。然而,高脑源性神经营养因子浓度(100和200 ng / mL)确实将释放增加至与神经生长因子相似的水平。总之,基底前脑胆碱能神经元长期暴露于神经生长因子(天),而其他神经营养蛋白则以较弱的方式增加了乙酰胆碱的释放,这取决于囊泡池和细胞外胆碱的可用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号